TKNO
HealthcareAlpha Teknova, Inc.
$4.00
+$0.10 (+2.56%)
Jan 5, 2026
Price History (1Y)
Analysis
Alpha Teknova, Inc. is a specialty and generic drug manufacturer operating in the healthcare sector. The company has a market capitalization of $214.12 million, indicating its scale is relatively small to medium-sized within its industry. Alpha Teknova employs 173 individuals, suggesting a modest workforce size. The financial health of Alpha Teknova appears challenged, with net income at -$18.22 million and EBITDA at -$11.59 million over the trailing twelve months (TTM). The company's profitability metrics are negative, including an operating margin of -38.4% and a profit margin of -45.8%. Returns on equity and assets are also negative, at -22.8% and -9.7%, respectively. On the balance sheet side, debt stands at $28.98 million, while cash is $22.12 million. Alpha Teknova's valuation metrics are mixed, with a forward P/E ratio of -10.26 indicating potential undervaluation or significant losses. The price to book and price to sales ratios are 2.95 and 5.38, respectively. Revenue growth over the past year is 9.2%, but earnings growth is not reported due to negative net income. The company has a dividend yield of N/A and pays out 0% of its profits in dividends.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Alpha Teknova, Inc.
Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary products include pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California.
Visit website →Key Statistics
- Market Cap
- $214.12M
- P/E Ratio
- N/A
- 52-Week High
- $10.37
- 52-Week Low
- $3.60
- Avg Volume
- 183.53K
- Beta
- 0.42
Company Info
- Exchange
- NGM
- Country
- United States
- Employees
- 173